3Bedlack RS,Vu T, Hammans S, et al. MNGIE neuropathy : five ca- ses mimicking chronic inflammatory demyelinating polyneuropathy [ J]. Muscle Nerve,2004,29:364 - 368.
4Celebi N, Sahin A, Canbay O,et al. Abdominal pain related to mito- chondrial neurogastrointestinal encephalomyopathy syndrome may benefit from splanchnic nerve blockade [ J ]. Paediatr Anaesth, 2006,16 : 1073 - 1076.
5Lara MC,Weiss B, Illa I, et al. Infusion of platelets transiently re- duces nucleoside overload in MNGIE [ J ]. Neurology, 2006,67: 1461 - 1463.
6De Vocht C,Ranquin A, Willaert R, et al. Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE [ J ]. J Control Release, 2009,137:246 - 254.
7Hirano M, Marti R, Casali C, et al. Allogeneic stem cell transplanta- tion corrects biochemical derangements in MNGIE [ J ]. Neurology, 2006,67:1458 - 1460.
8Torres-Torronteras J, Gomez A, Eixarch H, et al. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE [ J ]. Gene Ther, 2011,18 : 795 - 806.
9Halter J,Schupbach WM, Casali C, et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastroi- ntestinal encephalomyopathy(MNGIE) :a consensus conference pro- posal for a standardized approach [J]. Bone Marrow Transplant, 2010,46 (3) :330 - 337.
10Okamura K, Santa T, Nagae K, et al. Congenital oculoskeletal myopa- thy with abnormal muscle and liver mitochondria [ J]. J Neurol Sci, 1976,27:79 -91.
